logo-loader

NetScientific portfolio company Vortex enters manufacturing partnership with STRATEC

Published: 07:59 01 Nov 2018 GMT

Scientist
The agreement is also aimed at increasing VTX-1's prominence in the clinical space

NetScientific PLC’s (LON:NSCI) portfolio company, Vortex BioSciences, has secured a global manufacturing agreement with German firm STRATEC Consumables GmbH to scale up production of its VTX-1 liquid biopsy platform.

The healthcare IP commercialisation firm said STRATEC would assist Vortex in producing a customised chip, a crucial component of its automated platform, as well as assisting the company with scaling up to commercial viability and increasing the product’s prominence in the clinical space as a diagnostic and monitoring tool.

WATCH: 'Pivotal' moment for NetScientific's Glycotest Inc with $10mln financing

Francois Martelet, chief executive of NetScientific and chairman of Vortex, said the partnership would help create a reproducible process that would “allow Vortex's technology to enter the market and readily address demand as it surges”.

NetScientific holds a 66.1% stake in Vortex.

NetScientific: Significant Advancement with Strategic Goals

  NetScientific PLC (AIM:NSCI) CEO Dr Ilian Iliev discusses the substantial progress made in achieving its strategic objectives for 2023, despite facing challenging market conditions. Iliev told Proactive's Stephen Gunnion the company, a listed deep tech investor, has capitalized on the...

1 week, 2 days ago